. "FARMAKOTERAPIE HRANI\u010CN\u00CD PORUCHY OSOBNOSTI V \u010CASE"@cs . "136180" . "P(NS10301)" . "Grambalov\u00E1, Zuzana" . "FARMAKOTERAPIE HRANI\u010CN\u00CD PORUCHY OSOBNOSTI V \u010CASE" . "PHARMACOTHERAPY OF BORDERLINE PERSONALITY DISORDER DURING THE TIME"@en . . . . . "Mezi ambulantn\u00EDmi pacienty se vyskytuj\u00ED poruchy osobnosti v 30-50 % (Koenigsberg et al. 1985) a p\u0159ibli\u017En\u011B 15 % hospitalizovan\u00FDch pacient\u016F p\u0159ich\u00E1z\u00ED pro probl\u00E9my prim\u00E1rn\u011B souvisej\u00EDc\u00ED s poruchou osobnosti a v\u00EDce ne\u017E polovina hospitalizovan\u00FDch pacient\u016F trp\u00ED komorbidn\u00ED poruchou osobnosti. Hrani\u010Dn\u00ED porucha osobnosti (HPO) je nej\u010Dast\u011Bj\u0161\u00ED poruchou osobnosti v psychiatrick\u00E9 p\u00E9\u010Di. P\u0159ibli\u017En\u011B 15-20 % hospitalizovan\u00FDch pacient\u016F a 30-60 % v\u0161ech l\u00E9\u010Den\u00FDch poruch osobnosti tvo\u0159\u00ED pacienti s HPO (Phillips a Gunderson 1999). Hrani\u010Dn\u00ED porucha je pova\u017Eov\u00E1na za z\u00E1va\u017En\u00E9, chronick\u00E9 onemocn\u011Bn\u00ED s vysokou prevalenc\u00ED vedouc\u00ED k disabilit\u011B."@cs . . "4"^^ . . "978-80-263-0243-8" . "Grambal, Ale\u0161" . . "4"^^ . "Mezi ambulantn\u00EDmi pacienty se vyskytuj\u00ED poruchy osobnosti v 30-50 % (Koenigsberg et al. 1985) a p\u0159ibli\u017En\u011B 15 % hospitalizovan\u00FDch pacient\u016F p\u0159ich\u00E1z\u00ED pro probl\u00E9my prim\u00E1rn\u011B souvisej\u00EDc\u00ED s poruchou osobnosti a v\u00EDce ne\u017E polovina hospitalizovan\u00FDch pacient\u016F trp\u00ED komorbidn\u00ED poruchou osobnosti. Hrani\u010Dn\u00ED porucha osobnosti (HPO) je nej\u010Dast\u011Bj\u0161\u00ED poruchou osobnosti v psychiatrick\u00E9 p\u00E9\u010Di. P\u0159ibli\u017En\u011B 15-20 % hospitalizovan\u00FDch pacient\u016F a 30-60 % v\u0161ech l\u00E9\u010Den\u00FDch poruch osobnosti tvo\u0159\u00ED pacienti s HPO (Phillips a Gunderson 1999). Hrani\u010Dn\u00ED porucha je pova\u017Eov\u00E1na za z\u00E1va\u017En\u00E9, chronick\u00E9 onemocn\u011Bn\u00ED s vysokou prevalenc\u00ED vedouc\u00ED k disabilit\u011B." . "FARMAKOTERAPIE HRANI\u010CN\u00CD PORUCHY OSOBNOSTI V \u010CASE" . . "RIV/61989592:15110/12:33138985!RIV13-MZ0-15110___" . "[A92D90F303BF]" . "Pra\u0161ko Pavlov, J\u00E1n" . "PHARMACOTHERAPY OF BORDERLINE PERSONALITY DISORDER DURING THE TIME"@en . "4"^^ . "2012-06-07+02:00"^^ . . . . "BDZ; antidepressants; HPO"@en . "Among ambulatory patients with personality disorders occur in 30-50% (Koenigsberg et al., 1985) and approximately 15% of hospitalized patients comes to issues primarily related to personality disorder and more than half of hospitalized patients suffer from comorbid personality disorder. Borderline personality disorder (HPO) is the most common personality disorder in psychiatric care. Approximately 15-20% of hospitalized patients and 30-60% of all personality disorders treated are patients with HPO (Phillips and Gunderson 1999). Borderline disorder is considered a serious, chronic disease with high prevalence, leading to disability."@en . . . "IX. SJEZD \u010CESK\u00C9 PSYCHIATRICK\u00C9 SPOLE\u010CNOSTI \u010CLS JEP - %22Civilizace, \u010Das a du\u0161evn\u00ED poruchy%22" . "15110" . "RIV/61989592:15110/12:33138985" . . "Brno" . "Kamar\u00E1dov\u00E1, Dana" . "\u0160pindler\u016Fv Ml\u00FDn" . "Tribun EU" . . . . . "FARMAKOTERAPIE HRANI\u010CN\u00CD PORUCHY OSOBNOSTI V \u010CASE"@cs . .